As expected, NAP1L2 downregulation rendered CF more invulnerable to HG-induced CF activation, as seen by lower fibrosis, oxidative stress, and inflammation (Fig. 5H–M), indicating that periostin is a positive regulator of NAP1L2, leading to CF activation in diabetes. This evidence concerns the gene NAP1L2 and diabetes mellitus.